M2SR, a novel live single replication influenza virus vaccine, provides effective heterosubtypic protection in mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

M2SR, a novel live single replication influenza virus vaccine, provides effective heterosubtypic protection in mice

Published:2016-09 Issue:42 Volume:34 Page:5090-5098
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Sarawar Sally,Hatta Yasuko,Watanabe Shinji,Dias Peter,Neumann Gabriele,Kawaoka Yoshihiro,Bilsel Pamuk

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference45 articles.

1. Mortality due to influenza in the United States–an annualized regression approach using multiple-cause mortality data;Dushoff;Am J Epidemiol,2006

2. Early estimates of seasonal influenza vaccine effectiveness – United States, January 2015;Flannery;MMWR Morb Mortal Wkly Rep,2015

3. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial;Nichol;JAMA,1999

4. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity;Belshe;Vaccine,2010

5. Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season results;Pebody;Euro Surveill,2015

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and immunogenicity of the intranasal H3N2 M2-deficient single-replication influenza vaccine alone or coadministered with an inactivated influenza vaccine (Fluzone High-Dose Quadrivalent) in adults aged 65–85 years in the USA: a multicentre, randomised, double-blind, double-dummy, phase 1b trial;The Lancet Infectious Diseases;2024-07

2. Mucosal immunization with dual influenza/COVID-19 single-replication virus vector protects hamsters from SARS-CoV-2 challenge;Vaccine;2024-04

3. Intranasal Single-Replication Influenza Vector Induces Cross-Reactive Serum and Mucosal Antibodies against SARS-CoV-2 Variants;Vaccines;2023-06-05

4. Quadrivalent Formulation of Intranasal Influenza Vaccine M2SR (M2-Deficient Single Replication) Protects against Drifted Influenza A and B Virus Challenge;Vaccines;2023-04-04

5. Influenza Vaccine—Live;Plotkin's Vaccines;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3